As promised, I’d like to outline some of the reasons why I moved to Mead Johnson. There are several big picture or macro reasons why the move appealed to me:
- Engagement in standing up an “new” company. MJN just had an IPO as a carve out of Bristol Myers Squibb. While I’ve had a bit of experience integrating acquisitions, I’ve not been part of a divestiture. Ironically, many of the activities are quite similar, especially the process and application rationalization work on the IM side.
- Mead Johnson’s strategy: When you look at our vision, it is explicitly a premium strategy — “Our vision is to be the world’s premier pediatric nutrition company. “ There is a real research, quality, and product differentiation between the MJN brands and everyone else.
- Mead Johnson’s growth prospects: What surprised me most about MJN was how much growth there is in the pediatric nutrition market. In particular, there are great prospects globally. We’re already rolling in China and India is on the horizon.